July 21, 2025
12:00 PM ET

FACULTY CO-CHAIRS

Ananta Addala, DO, MPH

Assistant Professor
Department of Pediatrics
Division of Endocrinology & Diabetes
Lucile Packard Children’s Hospital
Stanford Medicine Children's Health
Stanford, California

 

Laura Jacobsen, MD

Assistant Professor
Associate Fellowship Program Director
Pediatric Endocrinology
University of Florida
Gainesville, Florida

PROGRAM DESCRIPTION

This virtual symposium will overview the benefits of screening for type 1 diabetes (T1D), as well as evidence-based screening and early detection methods to identify presymptomatic T1D in order to intervene early with disease-modifying therapies (DMTs) to delay disease progression. In addition, through expert faculty conversations, high impact animations, and patient cases, this activity will provide valuable insights to pediatric endocrinologists and other clinicians that see T1D patients on identifying appropriate patients who would benefit from treatment with DMTs, as well as considerations for administration of these therapies according to guidance and patient-specific factors.

TARGET AUDIENCE

This activity is designed to meet the educational needs of Pediatric Endocrinologists, as well as other clinicians and members of the healthcare team who treat patients with type 1 diabetes, including Adult Endocrinologists, Pediatricians, Internal Medicine Clinicians, Primary Care Providers, Endocrine Nurses, and Infusion Professionals. 

LEARNING OBJECTIVES

  • Incorporate evidence-based strategies for presymptomatic T1D screening into routine clinical practice to improve early detection
  • Interpret T1D screening results and effectively communicate next steps to support patient education and inform treatment decisions
  • Identify appropriate patients who would benefit from treatment with disease-modifying therapies for delaying T1D progression based on clinical evidence
  • Implement protocols to support safe and efficient administration of disease-modifying therapies for T1D according to guidance and patient-specific factors

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this virtual activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtual activity.

NURSES (ANCC) CREDIT DESIGNATION

Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.

COMMISSION ON DIETETIC REGISTRATION (CDR) CREDIT DESIGNATION

Med Learning Group designates this activity for a maximum of 1.0 CPEU.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF FINANCIAL RELATIONSHIPS

Ananta Addala, DO, MPH

Has nothing to disclose.

 

Laura Jacobsen, MD

Consulting Fee

Sanofi

All relevant financial relationships have been mitigated.

Content Review

The content of this activity was independently peer reviewed by a physician and nurse reviewer.

Individuals in Control of the Content of the Activity

The individuals in control of the content of this activity reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
Shannon Mutch MS, RN, OCN has nothing to disclose.
A medical reviewer from CME Peer Review LLC, has nothing to disclose.
Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
Shpetim Karandrea, PhD, Medical Director for Med Learning Group, has nothing to disclose.
Melissa A. Johnson, Program Director for Med Learning Group has nothing to disclose.
Millena De Brito, Associate Program Manager for Med Learning Group has nothing to disclose.
Aimee Meissner, Accreditation and Outcomes Manager for Med Learning Group has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at info@medlearninggroup.com

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group at info@medlearninggroup.com

 

custom image

This activity is provided by Med Learning Group.

This activity is supported by an educational grant from Sanofi US.

Copyright © 2025 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.


Published

July 17, 2025

Created by

Med Learning Group